News & Commentary
ArchiveArchive
Aug 08, 2006
HIV & AIDS: The South African Case
What happens when a drug exists and is available in sufficient quantities at no or low cost but the patient won’t take it? This is the question addressed in Tina Rosenberg’s New York Times Magazine article published this past Sunday on the HIV/AIDS.